Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000189248 | SCV000242880 | likely pathogenic | not provided | 2014-09-26 | criteria provided, single submitter | clinical testing | c.718_719delGCinsTT: p.Ala240Phe in exon 7 in the SCN2A gene (NM_021007.2). The normal sequence with the bases that are deleted in braces and the bases that are inserted in brackets is: TGGGG{GC}[TT]CCTG. The c.718_719delinsTT variant that is likely pathogenic has been identified in the SCN2A gene. The c.718_719delGCinsTT variant has not been published as pathogenic, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in an external variant database, indicating it is not a common benign variant in these populations. The c.718_719delinsTT variant results in an in-frame deletion of a single Alanine residue and the insertion of a single Phenylalanine residue, denoted p.A240F. This variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Additionally, this substitution occurs at a position that is highly conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this is a strong candidate for a pathogenic variant, however the possibility that it is a benign variant cannot be excluded. This variant has been observed de novo with confirmed parentage. |